The Quality Assurance Review Center (QARC) was developed to perform the quality assurance (QA) of the radiotherapy (Rad) components of Cooperative Group trials in multiple groups supported by the NCI and other organizations. It is structured to support emerging diagnostic imaging (Dl) programs and to apply new technologies to a large database repository for technical appraisal and outcome analyses. The general aim of this proposal is to continue to support the RAD Programs by maintaining an effective QA Program and quality improvement opportunities using established methods, while we explore emerging technologies for newer interactive approaches. Specifically, we will continue to perform and perfect the QA Programs. We will assist in the development of new protocols to produce unambiguous guidelines. Individual patient records will be reviewed on treatment plus a final review. Information about institution compliance will be supplied to the QA Subcommittees. The Qarc repository of large amounts of information relating to Rad trials must be digitally archived, maintained, manipulated and used for calculations of statistics, and to generate reports. Taking advantage of emerging computer technologies, new relational database management system has been created. We propose to continue development and implementation of this system. We have used Benchmarks for physics review and will continue to use protocol- specific questionnaires and benchmarks to assess how selected technical and physical problems are solved and to identify actions QARC can take to further the aims of trials. We will continue to develop a portfolio of model protocols, to assist Rad coordinator. With our support, a Diagnostic Imaging Comm. (Dl) was formed in POG. QARC will coordinate the acquisition of Dl data on protocol patients, whether or not they receive Rad. By this coordination we can reduce confusion and redundancy os submitted data. The members of the Di comm. will participate more extensively in review session at QARC, and use our database for outcome analysis and other Dl studies. We have agreed to undertake the acquisition, archiving all the DI data for all protocols in POG. The development of Teleradiography and Teleconferencing for future Virtual Review Sessions will be coordinated with the Dl Comm. QARC will continue to provide and stimulate the use of our extensive data files of over 21,000 cases as a research resource for the Groups for many types of analyses and research of technical aspects of Rad. We would like to provide an educational base for Fellows and young investigators to participate in QARC's review sessions and to undertake research opportunities utilizing the material which resides in our archives.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA029511-21
Application #
6137400
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Program Officer
Mooney, Margaret M
Project Start
1989-08-15
Project End
2000-12-31
Budget Start
2000-01-01
Budget End
2000-12-31
Support Year
21
Fiscal Year
2000
Total Cost
$1,050,715
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
FitzGerald, Thomas J; Bishop-Jodoin, Maryann (2018) Hodgkin Lymphoma: Differences in Treatment Between Europe and the United States/North America: Evolving Trends in Protocol Therapy. Clin Med Insights Oncol 12:1179554918754885
O'Neill, Allison F; Towbin, Alexander J; Krailo, Mark D et al. (2017) Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group. J Clin Oncol 35:3465-3473
Katzenstein, Howard M; Furman, Wayne L; Malogolowkin, Marcio H et al. (2017) Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee. Cancer 123:2360-2367
Garg, Madhur K; Zhao, Fengmin; Sparano, Joseph A et al. (2017) Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205). J Clin Oncol 35:718-726
Sparano, Joseph A; Lee, Jeannette Y; Palefsky, Joel et al. (2017) Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial. J Clin Oncol 35:727-733
Wozniak, Antoinette J; Moon, James; Thomas Jr, Charles R et al. (2015) A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533. Clin Lung Cancer 16:340-7
Trippett, Tanya M; Schwartz, Cindy L; Guillerman, R Paul et al. (2015) Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group report. Pediatr Blood Cancer 62:60-4
Dharmarajan, Kavita V; Friedman, Debra L; Schwartz, Cindy L et al. (2015) Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys 92:60-6
Dharmarajan, Kavita V; Friedman, Debra L; FitzGerald, T J et al. (2015) Radiotherapy quality assurance report from children's oncology group AHOD0031. Int J Radiat Oncol Biol Phys 91:1065-71
Servaes, Sabah; Khanna, Geetika; Naranjo, Arlene et al. (2015) Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children's Oncology Group. Pediatr Radiol 45:166-72

Showing the most recent 10 out of 60 publications